PTC Therapeutics, Inc. Share Price
PTC Therapeutics, Inc. (PTCT) had Share Price of $30.20 per share as of 2019-01-31, per its 10-Q filed 2019-08-06.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2021-02-25
- 2019-01-31: Share Price $30.20.
- 2018-04-30: Share Price $27.04.
- 2018-04-08: Share Price $27.04.
| Period end | Share Price |
|---|---|
| 2019-01-31 | $30.20 10-Q · filed 2019-08-06 |
| 2018-04-30 | $27.04 10-K · filed 2021-02-25 |
| 2018-04-08 | $27.04 10-Q · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |